Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials

INTRODUCTION: We conducted a post-hoc analysis on the effect of recombinant factor VIIa (rFVIIa) on coagulopathic patients from two randomized, placebo-controlled, double-blind trials of rFVIIa as an adjunctive therapy for bleeding in patients with severe trauma. METHODS: Blunt and penetrating traum...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizoli, Sandro B, Boffard, Kenneth D, Riou, Bruno, Warren, Brian, Iau, Philip, Kluger, Yoram, Rossaint, Rolf, Tillinger, Michael
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794494/
https://www.ncbi.nlm.nih.gov/pubmed/17184516
http://dx.doi.org/10.1186/cc5133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794494/
https://www.ncbi.nlm.nih.gov/pubmed/17184516
http://dx.doi.org/10.1186/cc5133

Ejemplares similares